The Paul Scherrer Institute, PSI, is the largest research institute for natural and engineering sciences within Switzerland. We perform world-class research in three main subject areas: Matter and Material; Energy and the Environment; and Human Health. By conducting fundamental and applied research, we work on long-term solutions for major challenges facing society, industry and science.
Current news from PSI
Festakt mit geladenen Gästen aus Politik, Wirtschaft und Wissenschaft
Heute fand am Paul Scherrer Institut PSI der Festakt
30 Jahre PSIstatt. Das PSI zeigte seinen Gästen auf, was es in den vergangenen drei Jahrzehnten an Ergebnissen hervorgebracht hat, von denen alle in der Schweiz profitieren können.
This news release is only available in German.
A radioactive agent, developed at the Paul Scherrer Institute PSI to fight an especially malignant form of thyroid cancer, has the potential to become a blockbuster drug. Due to its structure, it might also be able to dock onto cells of other tumours and destroy them with its radiation. The Lausanne-based biopharmaceutical company Debiopharm wants to further develop the PSI agent to the point where it is approved as a drug. Debiopharm and PSI have now created the contractual basis for this.
For the development of new medicinal agents, accurate knowledge of proteins is crucial. In a pilot experiment, researchers have now, for the first time, used the X-ray free-electron laser SwissFEL of PSI for the examination of protein crystals.